
Chuck Y. Mah
Examiner (ID: 16973, Phone: (571)272-7059 , Office: P/3677 )
| Most Active Art Unit | 3677 |
| Art Unit(s) | 3205, 3209, 3626, 3677, 3676 |
| Total Applications | 3997 |
| Issued Applications | 3297 |
| Pending Applications | 173 |
| Abandoned Applications | 568 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20206270
[patent_doc_number] => 20250275990
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-09-04
[patent_title] => ORAL SOLID DOSAGE FORMS COMPRISING CANNABINOIDS
[patent_app_type] => utility
[patent_app_number] => 19/210719
[patent_app_country] => US
[patent_app_date] => 2025-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23247
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 209
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19210719
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/210719 | Oral solid dosage forms comprising cannabinoids | May 15, 2025 | Issued |
Array
(
[id] => 19722783
[patent_doc_number] => 20250025534
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-23
[patent_title] => TOPICAL COMPOSITION FOR IMPROVED HEALING OF OPEN WOUNDS
[patent_app_type] => utility
[patent_app_number] => 18/818363
[patent_app_country] => US
[patent_app_date] => 2024-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14711
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18818363
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/818363 | Topical composition for improved healing of open wounds | Aug 27, 2024 | Issued |
Array
(
[id] => 19526474
[patent_doc_number] => 20240350376
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-24
[patent_title] => SKIN TREATMENT METHODS AND COMPOSITIONS FOR TRANSDERMAL DELIVERY OF ACTIVE AGENTS
[patent_app_type] => utility
[patent_app_number] => 18/751708
[patent_app_country] => US
[patent_app_date] => 2024-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21360
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18751708
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/751708 | SKIN TREATMENT METHODS AND COMPOSITIONS FOR TRANSDERMAL DELIVERY OF ACTIVE AGENTS | Jun 23, 2024 | Pending |
Array
(
[id] => 19447303
[patent_doc_number] => 20240307433
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-19
[patent_title] => BIOCOMPATIBLE MATERIAL AND METHODS FOR MAKING AND USING THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/673481
[patent_app_country] => US
[patent_app_date] => 2024-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20029
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18673481
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/673481 | BIOCOMPATIBLE MATERIAL AND METHODS FOR MAKING AND USING THEREOF | May 23, 2024 | Pending |
Array
(
[id] => 19447273
[patent_doc_number] => 20240307403
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-19
[patent_title] => DPP-IV INHIBITOR COMBINED WITH A FURTHER ANTIDIABETIC AGENT, TABLETS COMPRISING SUCH FORMULATIONS, THEIR USE AND PROCESS FOR THEIR PREPARATION
[patent_app_type] => utility
[patent_app_number] => 18/666901
[patent_app_country] => US
[patent_app_date] => 2024-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12229
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18666901
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/666901 | DPP-IV INHIBITOR COMBINED WITH A FURTHER ANTIDIABETIC AGENT, TABLETS COMPRISING SUCH FORMULATIONS, THEIR USE AND PROCESS FOR THEIR PREPARATION | May 16, 2024 | Pending |
Array
(
[id] => 20185865
[patent_doc_number] => 12396965
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-26
[patent_title] => Putrescine topical barrier formulation
[patent_app_type] => utility
[patent_app_number] => 18/659232
[patent_app_country] => US
[patent_app_date] => 2024-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6109
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18659232
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/659232 | Putrescine topical barrier formulation | May 8, 2024 | Issued |
| 18/704686 | COMPOSITION COMPRISING THE COMBINATION OF TWO PARTICULAR OXIDATION DYE PRECURSORS AND A FATTY ACID ESTER OF GLYCEROL | Apr 24, 2024 | Pending |
Array
(
[id] => 20315145
[patent_doc_number] => 12453684
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-28
[patent_title] => Personal care formulations
[patent_app_type] => utility
[patent_app_number] => 18/624804
[patent_app_country] => US
[patent_app_date] => 2024-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 21
[patent_no_of_words] => 6560
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18624804
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/624804 | Personal care formulations | Apr 1, 2024 | Issued |
Array
(
[id] => 19477374
[patent_doc_number] => 20240325416
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-03
[patent_title] => ORAL SOLID DOSAGE FORMS COMPRISING CANNABINOIDS
[patent_app_type] => utility
[patent_app_number] => 18/597717
[patent_app_country] => US
[patent_app_date] => 2024-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26942
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 156
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18597717
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/597717 | ORAL SOLID DOSAGE FORMS COMPRISING CANNABINOIDS | Mar 5, 2024 | Pending |
Array
(
[id] => 19279996
[patent_doc_number] => 20240216469
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-04
[patent_title] => SYNTHETIC TISSUE BARRIERS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/596376
[patent_app_country] => US
[patent_app_date] => 2024-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22779
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18596376
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/596376 | SYNTHETIC TISSUE BARRIERS AND USES THEREOF | Mar 4, 2024 | Pending |
Array
(
[id] => 19430788
[patent_doc_number] => 20240299286
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-12
[patent_title] => COSMETIC
[patent_app_type] => utility
[patent_app_number] => 18/595636
[patent_app_country] => US
[patent_app_date] => 2024-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11565
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18595636
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/595636 | COSMETIC | Mar 4, 2024 | Pending |
Array
(
[id] => 20076212
[patent_doc_number] => 12350246
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-08
[patent_title] => Eflornithine and sulindac, fixed dose combination formulation
[patent_app_type] => utility
[patent_app_number] => 18/435678
[patent_app_country] => US
[patent_app_date] => 2024-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 21039
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18435678
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/435678 | Eflornithine and sulindac, fixed dose combination formulation | Feb 6, 2024 | Issued |
Array
(
[id] => 19216428
[patent_doc_number] => 20240181132
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-06
[patent_title] => Cardiovascular Prostheses
[patent_app_type] => utility
[patent_app_number] => 18/406793
[patent_app_country] => US
[patent_app_date] => 2024-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12715
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18406793
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/406793 | Cardiovascular Prostheses | Jan 7, 2024 | Abandoned |
Array
(
[id] => 19125614
[patent_doc_number] => 20240130967
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-25
[patent_title] => PROCESS OF MAKING NANOEMULSION
[patent_app_type] => utility
[patent_app_number] => 18/397626
[patent_app_country] => US
[patent_app_date] => 2023-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21986
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18397626
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/397626 | Process of making nanoemulsion | Dec 26, 2023 | Issued |
Array
(
[id] => 20057154
[patent_doc_number] => 20250195376
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-06-19
[patent_title] => COMPOSITIONS CONTAINING BIS-ETHYLHEXYLOXYPHENOL METHOXYPHENYL TRIAZINE, SEMI-CRYSTALLINE POLYMER AND SCLEROGLUCAN GUM
[patent_app_type] => utility
[patent_app_number] => 18/543860
[patent_app_country] => US
[patent_app_date] => 2023-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9624
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18543860
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/543860 | COMPOSITIONS CONTAINING BIS-ETHYLHEXYLOXYPHENOL METHOXYPHENYL TRIAZINE, SEMI-CRYSTALLINE POLYMER AND SCLEROGLUCAN GUM | Dec 17, 2023 | Pending |
Array
(
[id] => 19186076
[patent_doc_number] => 20240164989
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-23
[patent_title] => MICROLAYER COEXTRUSION TO CREATE A TIME-RELEASE DRUG SUBSTANCE DELIVERY PRODUCT
[patent_app_type] => utility
[patent_app_number] => 18/528125
[patent_app_country] => US
[patent_app_date] => 2023-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4218
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18528125
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/528125 | MICROLAYER COEXTRUSION TO CREATE A TIME-RELEASE DRUG SUBSTANCE DELIVERY PRODUCT | Dec 3, 2023 | Pending |
Array
(
[id] => 19541608
[patent_doc_number] => 20240358644
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-31
[patent_title] => ENCAPSULATION OF LIPOPHILIC INGREDIENTS IN DISPERSIBLE SPRAY DRIED POWDERS SUITABLE FOR INHALATION
[patent_app_type] => utility
[patent_app_number] => 18/528153
[patent_app_country] => US
[patent_app_date] => 2023-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11081
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18528153
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/528153 | ENCAPSULATION OF LIPOPHILIC INGREDIENTS IN DISPERSIBLE SPRAY DRIED POWDERS SUITABLE FOR INHALATION | Dec 3, 2023 | Pending |
Array
(
[id] => 19096325
[patent_doc_number] => 20240115552
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-11
[patent_title] => MEBENDAZOLE POLYMORPH FOR TREATMENT AND PREVENTION OF TUMORS
[patent_app_type] => utility
[patent_app_number] => 18/525209
[patent_app_country] => US
[patent_app_date] => 2023-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8091
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18525209
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/525209 | MEBENDAZOLE POLYMORPH FOR TREATMENT AND PREVENTION OF TUMORS | Nov 29, 2023 | Abandoned |
Array
(
[id] => 19032360
[patent_doc_number] => 20240082175
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-14
[patent_title] => CANNABINOID AND MENTHOL TRANSDERMAL DELIVERY SYSTEMS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 18/513971
[patent_app_country] => US
[patent_app_date] => 2023-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9819
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18513971
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/513971 | CANNABINOID AND MENTHOL TRANSDERMAL DELIVERY SYSTEMS AND METHODS | Nov 19, 2023 | Pending |
Array
(
[id] => 19417425
[patent_doc_number] => 20240293548
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-05
[patent_title] => CONTACT LENS FOR PHOTODYNAMIC INACTIVATION OF GERMS, PRODUCT AND METHOD OF TREATING FUNGAL KERATITIS BY APPLYING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/506757
[patent_app_country] => US
[patent_app_date] => 2023-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7478
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18506757
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/506757 | CONTACT LENS FOR PHOTODYNAMIC INACTIVATION OF GERMS, PRODUCT AND METHOD OF TREATING FUNGAL KERATITIS BY APPLYING THE SAME | Nov 9, 2023 | Pending |